FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to immunology, and can be used for production of virosome adjuvants. Method of producing virosome adjuvants involves the following stages: (I) providing an aqueous composition which is uniaxial to virosomes, containing a membrane fusion protein; (II) dissolving an amphiphilic adjuvant in a pharmaceutically acceptable non-aqueous solvent which can form a homogeneous mixture with water; and (III) diluting said adjuvant solution in said aqueous virosome composition to induce incorporation of the adjuvant into the outer layer of the virosomal membrane while maintaining the ability of said virosome to fuse with the membrane. Group of inventions refers to pharmaceutical and immunogenic compositions containing an adjuvant virosome prepared by the above method, as well as to methods of immunization of a subject of cancer or viral disease.
EFFECT: there are presented methods for producing adjuvanted virosome and adjuvanted virosomes, obtained by said methods.
34 cl, 3 ex, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
FUNCTIONALLY RECONSTRUCTED ADJUVANT-CONTAINING VIRUS MEMBRANES | 2004 |
|
RU2348428C2 |
VIROSOMES CONTAINING HEMAGGLUTININ EXTRACTED FROM INFLUENZA VIRUS PRODUCED IN THE CELL LINES, COMPOSITIONS, CONTAINING SAID VIROSOMES, MEANS OF MANUFACTURING AND APPLICATIONS | 2008 |
|
RU2441647C2 |
CURTAILED SECRETABLE ASPARTYL-PROTEINASE 2 | 2008 |
|
RU2493255C2 |
ORALLY DISPERSABLE VACCINE CONTAINING VIROSOMES | 2019 |
|
RU2808276C2 |
NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
MUTANT ANTIGENS GAS57 AND GAS57 ANTIBODIES | 2008 |
|
RU2471497C2 |
LIPOSOMAL ADJUVANT COMPOSITIONS | 2016 |
|
RU2736642C2 |
ADJUVANT COMPOSITION CONTAINING ALUMINUM, AND CONTAINING ITS VACCINE COMPOSITION | 2016 |
|
RU2721417C2 |
IMMUNOGENIC COMPOSITION AND METHOD OF FUSED PROTEIN VACCINE DEVELOPMENT | 2004 |
|
RU2407749C2 |
USE OF MONOMYCOLYL GLYCEROL (MMG) AS ADJUVANT | 2008 |
|
RU2479317C2 |
Authors
Dates
2019-07-12—Published
2014-09-12—Filed